CS logo
small CS logo
Neurosurgeons of New Jersey-Ridgewood

Ridgewood, New Jersey, United States
Neurosurgeon in Ridgewood, New Jersey
1200 E Ridgewood Ave Suite 200 & 101, Ridgewood, NJ 07450

About Neurosurgeons of New Jersey-Ridgewood


"The Ridgewood office is Neurosurgeons of New Jersey’s flagship location in Bergen County. Our mission is to provide patients with outstanding surgical care by the most skilled neurosurgeons in the country utilizing state-of-the-art equipment for complex and minimally invasive surgeries of the brain and spine. All of our doctors are Board Certified and trained to explain complicated medical concepts in a clear, comprehensible manner so that patients and their families are equipped to make the best decisions about their health. Our goal is compassionate, effective treatment solutions for a wide variety of neurological conditions to help patients achieve the quality of life they deserve. Call our office to schedule a convenient appointment."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Neurosurgeons of New Jersey-Ridgewood


During the past decade, Neurosurgeons of New Jersey-Ridgewood conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Neurosurgeons of New Jersey-Ridgewood" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "Division of Cancer Control" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Neurosurgeons of New Jersey-Ridgewood


According to Clinical.Site data, the most researched conditions in "Neurosurgeons of New Jersey-Ridgewood" are "Recurrent Squamous Cell Lung Carcinoma" (3 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Invasive Breast Carcinoma" (2 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (2 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (2 trials). Many other conditions were trialed in "Neurosurgeons of New Jersey-Ridgewood" in a lesser frequency.

Clinical Trials Intervention Types at Neurosurgeons of New Jersey-Ridgewood


Most popular intervention types in "Neurosurgeons of New Jersey-Ridgewood" are "Drug" (20 trials), "Other" (15 trials), "Biological" (13 trials), "Procedure" (6 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Computed Tomography" (6 trials), "Laboratory Biomarker Analysis" (6 trials), "Carboplatin" (5 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Neurosurgeons of New Jersey-Ridgewood


The vast majority of trials in "Neurosurgeons of New Jersey-Ridgewood" are 19 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at Neurosurgeons of New Jersey-Ridgewood


Currently, there are NaN active trials in "Neurosurgeons of New Jersey-Ridgewood". undefined are not yet recruiting, 6 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurosurgeons of New Jersey-Ridgewood, 1 suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Neurosurgeons of New Jersey-Ridgewood, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".